179 related articles for article (PubMed ID: 22791158)
1. The novel non-steroidal selective androgen receptor modulator S-101479 has additive effects with bisphosphonate, selective estrogen receptor modulator, and parathyroid hormone on the bones of osteoporotic female rats.
Furuya K; Yamamoto N; Ohyabu Y; Makino A; Morikyu T; Ishige H; Kuzutani K; Endo Y
Biol Pharm Bull; 2012; 35(7):1096-104. PubMed ID: 22791158
[TBL] [Abstract][Full Text] [Related]
2. Bone anabolic effects of S-40503, a novel nonsteroidal selective androgen receptor modulator (SARM), in rat models of osteoporosis.
Hanada K; Furuya K; Yamamoto N; Nejishima H; Ichikawa K; Nakamura T; Miyakawa M; Amano S; Sumita Y; Oguro N
Biol Pharm Bull; 2003 Nov; 26(11):1563-9. PubMed ID: 14600402
[TBL] [Abstract][Full Text] [Related]
3. Effect of a bisphosphonate and selective estrogen receptor modulator on bone remodeling in streptozotocin-induced diabetes and ovariectomized rat model.
Lee YS; Gupta R; Kwon JT; Cho DC; Seo YJ; Seu SY; Park EK; Han I; Kim CH; Sung JK; Kim KT
Spine J; 2018 Oct; 18(10):1877-1887. PubMed ID: 29793000
[TBL] [Abstract][Full Text] [Related]
4. Effects of raloxifene and alendronate on non-enzymatic collagen cross-links and bone strength in ovariectomized rabbits in sequential treatments after daily human parathyroid hormone (1-34) administration.
Kimura S; Saito M; Kida Y; Seki A; Isaka Y; Marumo K
Osteoporos Int; 2017 Mar; 28(3):1109-1119. PubMed ID: 27796444
[TBL] [Abstract][Full Text] [Related]
5. Sequential Treatment of Estrogen Deficient, Osteopenic Rats with Alendronate, Parathyroid Hormone (1-34), or Raloxifene Alters Cortical Bone Mineral and Matrix Composition.
Taylor EA; Donnelly E; Yao X; Johnson ML; Amugongo SK; Kimmel DB; Lane NE
Calcif Tissue Int; 2020 Mar; 106(3):303-314. PubMed ID: 31784772
[TBL] [Abstract][Full Text] [Related]
6. Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol.
Bitto A; Burnett BP; Polito F; Marini H; Levy RM; Armbruster MA; Minutoli L; Di Stefano V; Irrera N; Antoci S; Granese R; Squadrito F; Altavilla D
Br J Pharmacol; 2008 Nov; 155(6):896-905. PubMed ID: 18695641
[TBL] [Abstract][Full Text] [Related]
7. Effect of Sequential Treatment with Bisphosphonates After Teriparatide in Ovariectomized Rats: A Direct Comparison Between Risedronate and Alendronate.
Yano T; Yamada M; Inoue D
Calcif Tissue Int; 2017 Jul; 101(1):102-110. PubMed ID: 28337514
[TBL] [Abstract][Full Text] [Related]
8. New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats.
Ma YL; Bryant HU; Zeng Q; Schmidt A; Hoover J; Cole HW; Yao W; Jee WS; Sato M
Endocrinology; 2003 May; 144(5):2008-15. PubMed ID: 12697709
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K
Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450
[TBL] [Abstract][Full Text] [Related]
10. Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats.
Li X; Ominsky MS; Warmington KS; Niu QT; Asuncion FJ; Barrero M; Dwyer D; Grisanti M; Stolina M; Kostenuik PJ; Simonet WS; Paszty C; Ke HZ
Endocrinology; 2011 Sep; 152(9):3312-22. PubMed ID: 21733832
[TBL] [Abstract][Full Text] [Related]
11. Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats.
Bourrin S; Ammann P; Bonjour JP; Rizzoli R
Bone; 2002 Jan; 30(1):195-200. PubMed ID: 11792585
[TBL] [Abstract][Full Text] [Related]
12. Combination treatment with a selective androgen receptor modulator q(SARM) and a bisphosphonate has additive effects in osteopenic female rats.
Vajda EG; Hogue A; Griffiths KN; Chang WY; Burnett K; Chen Y; Marschke K; Mais DE; Pedram B; Shen Y; van Oeveren A; Zhi L; López FJ; Meglasson MD
J Bone Miner Res; 2009 Feb; 24(2):231-40. PubMed ID: 18847323
[TBL] [Abstract][Full Text] [Related]
13. Differing Effects of Parathyroid Hormone, Alendronate, and Odanacatib on Bone Formation and on the Mineralization Process in Intracortical and Endocortical Bone of Ovariectomized Rabbits.
Vrahnas C; Buenzli PR; Pearson TA; Pennypacker BL; Tobin MJ; Bambery KR; Duong LT; Sims NA
Calcif Tissue Int; 2018 Dec; 103(6):625-637. PubMed ID: 30019315
[TBL] [Abstract][Full Text] [Related]
14. Effects of the selective estrogen receptor modulator ospemifene on bone in rats.
Kangas L; Härkönen P; Väänänen K; Peng Z
Horm Metab Res; 2014 Jan; 46(1):27-35. PubMed ID: 24108389
[TBL] [Abstract][Full Text] [Related]
15. [Combination or sequential treatment using PTH and anti-resorption therapies].
Suzuki H; Takeuchi Y
Clin Calcium; 2012 Mar; 22(3):415-20. PubMed ID: 22370309
[TBL] [Abstract][Full Text] [Related]
16. Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats.
El-Shitany NA; Hegazy S; El-Desoky K
Phytomedicine; 2010 Feb; 17(2):116-25. PubMed ID: 19577454
[TBL] [Abstract][Full Text] [Related]
17. Raloxifene but not alendronate can compensate the impaired osseointegration in osteoporotic rats.
Faverani LP; Polo TOB; Ramalho-Ferreira G; Momesso GAC; Hassumi JS; Rossi AC; Freire AR; Prado FB; Luvizuto ER; Gruber R; Okamoto R
Clin Oral Investig; 2018 Jan; 22(1):255-265. PubMed ID: 28357643
[TBL] [Abstract][Full Text] [Related]
18. Effects of SP500263, a novel selective estrogen receptor modulator, on bone, uterus, and serum cholesterol in the ovariectomized rat.
Sutherland MK; Brady H; Gayo-Fung LM; Leisten J; Lipps SG; McKie JA; O'Leary E; Patnaik N; Anderson DW; Bhagwat SS; Stein B
Calcif Tissue Int; 2003 Jun; 72(6):710-6. PubMed ID: 14563000
[TBL] [Abstract][Full Text] [Related]
19. A combined treatment with selective androgen and estrogen receptor modulators prevents bone loss in orchiectomized rats.
Komrakova M; Büchler G; Böker KO; Lehmann W; Schilling AF; Roch PJ; Taudien S; Hoffmann DB; Sehmisch S
J Endocrinol Invest; 2022 Dec; 45(12):2299-2311. PubMed ID: 35867330
[TBL] [Abstract][Full Text] [Related]
20. [Skeletal biomechanical properties improvement in ovariectomized osteoporotic rats of teriparatide was retarded by alendronate].
Li M; Jiao J; Meng XW; Zhou XY; Xing XP; Xia WB; Wang O; Jiang Y; Liu HC; Hu YY
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):104-7. PubMed ID: 16624115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
